NHSBSA - Freedom of Information

You are at: NHSBSA Home Page | Freedom of Information

Previous Request List - Detail

Request Reference: 8823 Request Date: 11 Oct 2019
Request: Good afternoon, I write under the Freedom of Information Act 2000 to request the following information, based on Written Parliamentary Question 284234. How many prescriptions on the NHS have been written for unlicensed Cannabis-based medicinal products since November 2018? And how many of these prescriptions have been reimbursed following submission to the NHS Business Services Authority? How many private prescriptions have been written for Cannabis-based medicinal products since November 2018? Please provide any details that can be released concerning the 12 unlicensed Cannabis-based medicinal products that were submitted to the NHS Business Services Authority for reimbursement between November 2018 and June 2019, as evidenced in Written Parliamentary Question 284234. If possible, please include from within which CCG the application arose from. Some parts of the request may be easier to answer than others. Should this be the case, please release information as soon as possible. I would prefer to receive the information electronically. If you require any clarification please contact me under your Section 16 duty to provide advice and assistance if you find any aspect of this FOI request problematic. I look forward to your response as soon as possible within 20 days. Yours sincerely, [Name Redacted] [On 15 November 2019 you clarified the following]Regarding Question 4, by ‘application’ I mean the geographical location of where the submission originated from- please provide the region and CCG/Trust. Regarding Question 4, by ‘details’ I mean please provide me with any information held concerning the unlicensed Cannabis-based medicinal products that were reimbursed including, but not limited to,: • The propriety (brand) names of the unlicensed Cannabis-based medicinal products that were prescribed and submitted to the NHSBSA for reimbursement? • What the value of reimbursement of the unlicensed Cannabis-based medicinal products was in each case? • The name of the pharmacy from which each submission for an unlicensed Cannabis-based medicinal product to be reimbursed by the NHSBSA originated from? • Any other information held by NHSBSA regarding the prescriptions for cannabis-based medicines that have been prescribed and submitted to the NHSBSA.

Status: Complete
Response Date: 08 Nov 2019
Response: Please see attached response.

References: